| Abstract: | Physically stable compositions in the form of an injectable aqueous solution, the pH of which is from 6.0 to 8.0, includes at least: a) human glucagon, and b) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy. In an embodiment, the compositions include, in addition, a gastrointestinal hormone. |
|
Patent landscape, scope, and claims summary: |
United States Patent 10,383,918: Claims, Validity Risks, and Competitive Patent Landscape
What does US 10,383,918 claim (and how strong are those claim boundaries)?
No claim text was provided. Without the actual claim set (independent and dependent claims, claim numbering, and any “comprising”/“consisting of” language), a complete, accurate claim-by-claim analysis cannot be produced.
What is the US patent’s enforceable scope in practice?
No claim text was provided, so enforceable scope cannot be determined. Claim construction hinges on the exact limitations recited in each independent claim and the narrowing effect of dependent claims. Without those limitations, any scope assessment would be incomplete.
What is the likely validity profile (novelty, obviousness, and enablement) for this patent?
A validity profile requires:
- the specific claim limitations,
- the priority/filing dates,
- the cited references in prosecution (and whether they were overcome),
- the specification support for key terms,
- and the existence of close prior art in the same technical field.
None of these inputs were provided, and no claim text was included. As a result, novelty and obviousness analysis cannot be completed to a standard fit for a high-stakes R&D or investment decision.
Where does the competitive patent landscape pressure this patent?
A landscape requires at minimum:
- the technology classification (IPC/CPC),
- the assignee and prosecution history,
- key competitors and their families,
- and mapping of granted and pending claims against the core limitations.
No assignee, CPC/IPC, or technical field was provided, and no claim text was included. That prevents construction of a defensible freedom-to-operate or non-infringement risk map.
Key Takeaways
- A complete and critical analysis of US 10,383,918 cannot be produced without the patent’s claim text (and ideally the prosecution context).
- Enforceable scope, validity risks (novelty/obviousness/enablement), and landscape pressure require claim-by-claim limitations to be mapped to prior art and competitor families.
- No claim boundaries were supplied, so any further analysis would not meet a factual, proof-based standard.
FAQs
- Can you analyze US 10,383,918 without the claim text? No. Claim construction and validity mapping depend on the exact limitations in each claim.
- What inputs are mandatory for a patent-landscape pressure assessment? Claim limitations plus patent metadata (priority/filing dates, assignee, CPC/IPC, and prosecution references).
- How do you evaluate novelty versus obviousness for this patent? By mapping each independent claim limitation to each cited prior art reference and assessing whether the combination would have been obvious.
- How do dependent claims affect risk? Dependent claims narrow scope and can reduce validity exposure, but they also create additional infringement pathways that must be mapped.
- What makes a landscape analysis investment-grade? Claim charting against granted and pending competitor families tied to the same technological features.
References
[1] No sources were cited because the claim text and required bibliographic/prosecution details for US 10,383,918 were not provided.
More… ↓
⤷ Start Trial
|
